BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Spring Bank Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2017 Financial and Operational Results

  Quarter highlighted by data presentations at two conferences and the initiation of research collaborations.

  October 31, 2017

   · 

  11 min read
• Business

  Ritter Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update

  The company reported a net loss attributable to common stockholders of approximately $2.0 million compared to a net loss of approximately $3.5 million for the third quarter of 2016.

  October 31, 2017

   · 

  6 min read
• Lone Star Bio

  Invitae Presents Validation of a Novel NGS-based Preimplantation Genetic Screening Technology to Identify the Most Frequent Chromosomal Causes of Miscarriage

  Invitae is presenting validation data for a novel, NGS-based PGS technology that accurately identifies certain chromosomal abnormalities potentially missed on other PGS platforms.

  October 31, 2017

   · 

  6 min read
• Avella Selected by Astra to Distribute CALQUENCE (acalabrutinib)

  CALQUENCE (acalabrutinib), was granted accelerated approval today by the FDA.

  October 31, 2017

   · 

  2 min read
• Business

  3D Systems Reports Third Quarter 2017 Financial Results

  For the third quarter of 2017, the company reported revenue of $152.9M compared to $156.4M in the third quarter of the previous year.

  October 31, 2017

   · 

  26 min read
• Drug Development

  Allergan Presented New Phase III Data of Ulipristal Acetate in Women with Uterine Fibroids at the ASRM Annual Congress

  Allergan presented new analyses of VENUS II, the second of two pivotal Phase III clinical trials evaluating the efficacy and safety of ulipristal acetate (UPA), an investigational drug for the treatment of abnormal uterine bleeding in women with uterine fibroids.

  October 31, 2017

   · 

  10 min read
• Business

  ReShape Lifesciences to Host Third Quarter Conference Call on November 14, 2017

  ReShape Lifesciences today announced that it will host a conference call to discuss financial results for the third quarter of 2017 on Tuesday, November 14, 2017 at 1:30 PM Pacific Time.

  October 31, 2017

   · 

  1 min read
• Biotech Bay

  Eiger BioPharma Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriter’s Option to Purchase Additional Shares

  The offering was made under the company’s effective shelf registration statement and resulted in net proceeds to the company of approximately $19.5M, after underwriting discounts and commissions and estimated offering expenses.

  October 31, 2017

   · 

  2 min read
• Business

  Senseonics Holdings Reports Third Quarter 2017 Financial Results

  Revenue was $2.1 million for the third quarter of 2017, compared to $37,000 for the third quarter of 2016.

  October 31, 2017

   · 

  7 min read
• BIOCORP Won CPhI Pharma Awards 2017, in the “IT, mHealth and Digitalisation” Category, for Its Entire Connected Devices Range

  The event took place on October 24 at the Intercontinental Hotel in Frankfurt, Germany.

  October 31, 2017

   · 

  3 min read